In this article, Stella Blackburn discusses work conducted by the Innovative Medicines Initiative (IMI) and the PROTECT consortium (Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium), led by the European Medicines Agency.  The study looked at whether it’s possible to collect data directly from pregnant women without the intervention of healthcare professionals.

The article was published in April 2015 by The Pregnancy & Medicine Initiative, which aims to raise awareness and help address the information vacuum concerning the use of medicines and medical treatment in pregnancy. Visit